← All trials
NCT01236573
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2010
- Primary completion
- Mar 1, 2015
- Completion date
- Mar 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 34
- Arms / groups
- 11 / —
- Source
- AACT · pre-existing
Sponsors
- National Institutes of Health (NIH)Lead sponsor
- National Cancer Institute (NCI)Overall official - principal investigator
- National Cancer Institute (NCI)Collaborator
- National Institutes of Health (NIH)Reponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.